Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The zinc-coordinated nanogel therapy speeds up wound healing after pancreas surgery by balancing metabolism and fighting bacteria.

The new model helps understand and develop treatments for genetic skin disorders like AEC.

Aptamers can improve wound healing and promote hair growth.

Peptides are being used to create biomaterials that can help diagnose and treat diseases.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

A new method speeds up insulin amyloid fibril growth, useful for studying diseases.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Chirality affects the structure, strength, and function of peptide-based hydrogels.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

A new method creates precise, stable microscale structures with reduced friction and potential for complex designs.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Ptch2 plays a key role in controlling stem cell function and the ability to regenerate after birth.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

Engineered polypeptide-based systems can improve cancer treatment by targeting specific sites and reducing side effects.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

Targeting LPA could help treat skin disorders.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

A parasite molecule can speed up skin healing and reduce scarring.